SBIR/STTR Research Award
FY23. SBIR TOPIC 167 PHASE I: ULTRAPORTABLE LAB-ON-A-CHIP BIOSENSOR SYSTEM FOR RAPID POSTMORTEM TOXICOLOGY. PERIOD OF PERFORMANCE: 9/27/23-9/26/24
Award amount
$400,000Program and phase
SBIR · Phase IAward year
2023Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- PORTABLE DIAGNOSTIC SYSTEMS INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- F3PMSK7KM3K8
- Solicitation number
- PHS-2023-1
- Topic code
- 167
Research abstract
Currently, suspected drug overdoses represent more than 1 in 6 death investigations, and both coroner and medical examiner offices are facing overwhelming caseloads that require comprehensive toxicology analysis. Therefore, there is a critical and immediate need to improve the workflow in suspected fatal overdose cases with new postmortem toxicology screening tools. This Phase I project from Portable Diagnostic Systems, Inc is to develop an Ultraportable Lab-On-A-Chip Biosensor System For Rapid Postmortem Toxicology.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- FY25. SBIR TOPIC 167 PHASE II: ULTRAPORTABLE LAB-ON-A-CHIP BIOSENSOR SYSTEM FOR RAPID POSTMORTEM TOXICOLOGY. PERIOD OF PERFORMANCE: 9/01/25-8/31/27
- Microfluidic immunoassay as a polysubstance oral fluid screening tool for law enforcement to rapidly identify recent drug use in traffic stops to reduce traffic fatalities and injuries.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- COUPLED ACOUSTICAL WAVE MICROPILLAR DETECTION OF DRUGS IN BLOOD POSTMORTEM
- FY23. SBIR TOPIC 167 PHASE I: AN ARRAY-BASED MULTIPLEX IMMUNOASSAY FOR POSTMORTEM TOXICOLOGY SCREENING
Research funding history
3 SBIR/STTR records share this UEI (2023–2025). Reported award amounts total $2,675,766. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services